Endometrioid stromal and related neoplasms of the cervix

Summary

Endometrioid stromal and related neoplasms of the cervix (MONDO:0003031) is a disease. A subtype of female reproductive system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	endometrioid stromal and related neoplasms of the cervix
Mondo ID	MONDO:0003031
DOID	DOID:4521
NCIT	C40218
UMLS	C4289586
MedGen	927118
Is cancer (heuristic)	no

Also known as: cervix endometrial stromal tumour · endometrioid stromal and related neoplasms of the cervix · endometrioid stromal and related tumors of the cervix · endometrioid stromal and related tumours of the cervix

Disease family

This is a subtype of female reproductive system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › female reproductive system disorder › female reproductive system neoplasm › endometrioid stromal and related neoplasms of the cervix

Related subtypes (10): benign female reproductive system neoplasm, female reproductive organ cancer, endometrioid tumor, gestational trophoblastic neoplasm, vulvar neoplasm, vaginal neoplasm, ovarian neoplasm, fallopian tube neoplasm, tumor of uterus, endometrioid stromal and related neoplasms

Subtypes (1): endometrioid stromal sarcoma of the cervix

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.